Schistosomiasis is a major public health problem that afflicts an estimated 200 million individuals in more than 74 endemic countries. 1 The most serious manifestation of the disease is attributed to egg granulomas and hepatic fibrosis following eggs encapsulation in the liver. Chronic egg granulomas in the liver can cause severe complications including liver cirrhosis, portal hypertension and even liver failure. 2 The activation of hepatic stellate cells (HSCs), leading to secretion of extracellular matrix, is central to hepatic fibrosis progression, and this process is tied to lipid metabolism. 3 The liver is a central hub for lipid metabolism, which can synthesize and release various lipoprotein and lipid metabolism enzymes, and thus affect the balance of lipid metabolism. 3,4 Increasing findings indicate that Schistosoma infection is associated with lipid metabolism disorder. 5-8 Apolipoprotein E (ApoE), synthesized principally in the liver, plays an essential role in lipid metabolism and regulation of immune response. 9,10 The liver synthesizes approximately two thirds or even three fourths of serum ApoE in the plasma. ApoE plays a key role in the severity and progression of some liver diseases. 11 Several studies demonstrate the association of ApoE with the liver outcomes in hepatitis C virus (HCV) and hepatitis B virus (HBV) infections. 12-14 One study reports that ApoE is a contributing factor for efficient HBV infection, 15 while the other indicates